Company intelligence / Profile preview

Grey Ghost Capital

United States

Ownership: Private
Development stage: Other

Overview

Grey Ghost Capital is a private investment firm founded by Meghan FitzGerald that focuses exclusively on healthcare, with $50M assets under management and a portfolio of 22 healthcare investments as of 2023. The company does not run clinical trials or pipelines itself but invests in healthtech, biotech, and healthcare service startups.

Industry: Investors

Partnerships

4G ClinicalABB OpticalRayusRoivantTenet Healthcare

Beyond the preview

Go deeper on Grey Ghost Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Grey Ghost Capital.

Explore the full profile